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An incorrect word, XAF1, was inadvertently included in this article; the correct word is ‘‘XIAP.’’ In column 3 on page 12, the sentence
beginning on line 7 should read as follows: ‘‘On the basis of these results, the investigators suggested that inactivation of ZBTB7A
and TP53, potentially through XIAP-mediated inhibition of apoptosis and SRD5A1-mediated dihydrotestosterone production, may
provide survival benefit to prostate cancer cells following ADT and promote the CRPC phenotype.’’ The authors apologize for any
inconvenience or confusion that may have been caused by this error.Mutant p53 Prolongs NF-kB Activation
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Dr. Rosenfeld’s name was printed incorrectly as ‘‘Rozenfeld’’ in the original article. It appears correctly in this erratum.272 Cancer Cell 24, 272, August 12, 2013 ª2013 Elsevier Inc.
